Medtronic LABS and the Ministry of Health have announced the expansion of the Empower Health program. This is a landmark public-private partnership that addresses the most pressing chronic diseases, like high blood pressure and diabetes, throughout Kenya.
Medtronic Labs
Philips Therapeutics
Royal Danish Embassy.
Considering the economic vulnerabilities faced by many of the patients living with diabetes in the country, the Affordability initiative seeks to ensure affordable insulins supplied reach patients. This will ultimately reach more people with quality care and treatments, and empower people with diabetes to better manage their condition while at the same time building the capacity of health care workers.
Speaking at the launch of the initiative in Nairobi, Emil Larsen, CVP Business Area Middle East, Africa and CIS of Novo Nordisk said, “The main objective of the initiative is to accelerate access to affordable treatment for patients living with diabetes in Africa in a sustainable manner in four key areas. These are capacity, affordability, reach and empowerment thus ensuring more patients will be treated to defeat diabetes in Middle Africa, especially at this time of the celebration of 100 years of the discovery of Insulin
Novo Nordisk, partners launch affordable insulin project in Kenya africabusinesscommunities.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from africabusinesscommunities.com Daily Mail and Mail on Sunday newspapers.
Diabetics no longer need to worry about storing insulin in cooler temperatures
Wednesday February 10 2021
Diabetes is among the major non-communicable diseases (NCD) affecting people in Kenya.
Figures from the most current 2019 International Diabetes Atlas report indicates that over half a million (552,400) Kenyans - aged between 20 and 79 years - suffer from the condition.
Diabetes is among the major non-communicable diseases (NCD) affecting people in Kenya.
Figures from the most current 2019 International Diabetes Atlas report indicates that over half a million (552,400) Kenyans - aged between 20 and 79 years - suffer from the condition.
According to the report, these numbers are likely to be an underrepresentation of the real picture on the ground since it is estimated that about 40 percent (243,500) of people with the condition in Kenya are undiagnosed and are thus unaware that they have diabetes.